WO2002011683A1 - Topical gel delivery system - Google Patents
Topical gel delivery system Download PDFInfo
- Publication number
- WO2002011683A1 WO2002011683A1 PCT/US2001/023341 US0123341W WO0211683A1 WO 2002011683 A1 WO2002011683 A1 WO 2002011683A1 US 0123341 W US0123341 W US 0123341W WO 0211683 A1 WO0211683 A1 WO 0211683A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- composition
- water
- corticosteroid
- antibiotic
- polymer
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
- A61K31/7036—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin having at least one amino group directly attached to the carbocyclic ring, e.g. streptomycin, gentamycin, amikacin, validamycin, fortimicins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/7056—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing five-membered rings with nitrogen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Dermatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Inorganic Chemistry (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cosmetics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Description
Claims
Priority Applications (17)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2001279002A AU2001279002B2 (en) | 2000-08-03 | 2001-07-24 | Topical gel delivery system |
CN018150659A CN1460013B (en) | 2000-08-03 | 2001-07-24 | Topical gel delivery system |
EP01957238A EP1304992B1 (en) | 2000-08-03 | 2001-07-24 | Topical gel delivery systems for treating skin disorders |
JP2002517021A JP4988129B2 (en) | 2000-08-03 | 2001-07-24 | Topical gel delivery system |
MXPA03001006A MXPA03001006A (en) | 2000-08-03 | 2001-07-24 | Topical gel delivery system. |
AT01957238T ATE429922T1 (en) | 2000-08-03 | 2001-07-24 | TOPICAL GEL DELIVERY SYSTEMS FOR THE TREATMENT OF SKIN DISEASES |
SI200130926T SI1304992T1 (en) | 2000-08-03 | 2001-07-24 | Topical gel delivery systems for treating skin disorders |
DE60138549T DE60138549D1 (en) | 2000-08-03 | 2001-07-24 | TOPICAL GEL DELIVERY SYSTEMS FOR THE TREATMENT OF SKIN DISEASES |
BR0113247-4A BR0113247A (en) | 2000-08-03 | 2001-07-24 | Composition, method for the treatment of skin disorders in a human, method for the preparation of a composition |
CA2417646A CA2417646C (en) | 2000-08-03 | 2001-07-24 | Topical gel delivery system |
DK01957238T DK1304992T3 (en) | 2000-08-03 | 2001-07-24 | Topical gel delivery system for the treatment of skin disorders |
PL360589A PL213237B1 (en) | 2000-08-03 | 2001-07-24 | Topical gel delivery system |
KR1020037001564A KR100840169B1 (en) | 2000-08-03 | 2001-07-24 | Topical gel delivery system |
AU7900201A AU7900201A (en) | 2000-08-03 | 2001-07-24 | Topical gel delivery system |
BE2013C060C BE2013C060I2 (en) | 2000-08-03 | 2013-10-30 | |
CY2014005C CY2014005I2 (en) | 2000-08-03 | 2014-01-23 | TOPICAL GEL DELIVERY SYSTEMS FOR THE THERAPEUTIC TREATMENT OF SKIN DISORDERS |
FR14C0053C FR14C0053I1 (en) | 2000-08-03 | 2014-07-04 | TOPICAL GEL DELIVERY SYSTEM FOR THE TREATMENT OF SKIN DISORDERS |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/632,508 US6387383B1 (en) | 2000-08-03 | 2000-08-03 | Topical low-viscosity gel composition |
US09/632,508 | 2000-08-03 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2002011683A1 true WO2002011683A1 (en) | 2002-02-14 |
Family
ID=24535786
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2001/023341 WO2002011683A1 (en) | 2000-08-03 | 2001-07-24 | Topical gel delivery system |
Country Status (25)
Country | Link |
---|---|
US (2) | US6387383B1 (en) |
EP (2) | EP1304992B1 (en) |
JP (1) | JP4988129B2 (en) |
KR (2) | KR20080036246A (en) |
CN (2) | CN1460013B (en) |
AR (1) | AR030093A1 (en) |
AT (1) | ATE429922T1 (en) |
AU (2) | AU2001279002B2 (en) |
BE (1) | BE2013C060I2 (en) |
BR (1) | BR0113247A (en) |
CA (1) | CA2417646C (en) |
CY (3) | CY1109189T1 (en) |
DE (1) | DE60138549D1 (en) |
DK (2) | DK2052714T3 (en) |
ES (2) | ES2437321T3 (en) |
FR (1) | FR14C0053I1 (en) |
HK (1) | HK1125847A1 (en) |
LU (1) | LU92401I2 (en) |
MX (1) | MXPA03001006A (en) |
PL (1) | PL213237B1 (en) |
PT (2) | PT2052714E (en) |
RU (1) | RU2251410C2 (en) |
SI (2) | SI2052714T1 (en) |
WO (1) | WO2002011683A1 (en) |
ZA (1) | ZA200301037B (en) |
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002074290A3 (en) * | 2001-03-15 | 2004-02-19 | Agis Ind 1983 Ltd | Dermatological preparations containing a nsaid |
WO2006006054A1 (en) * | 2004-07-09 | 2006-01-19 | Universita' Degli Studi Di Roma 'tor Vergata' | Method for preparing a polymeric biocompatible system for the pharmacological release by topic use and use of said system |
US7175850B2 (en) | 1998-12-23 | 2007-02-13 | Idea Ag | Formulation for topical non-invasive application in vivo |
JP2007522077A (en) * | 2003-08-21 | 2007-08-09 | アクセス ファーマシューティカルズ, インコーポレイテッド | Liquid formulations for prevention and treatment of mucosal diseases and disorders |
WO2010111115A1 (en) * | 2009-03-24 | 2010-09-30 | Bausch & Lomb Incorporated | Method for preparing suspensions of low-solubility materials |
EP2329849A1 (en) * | 2009-11-18 | 2011-06-08 | Galderma Research & Development | Combination of alpha-2 adrenergic receptor agonist and non-steroidal anti-inflammatory agent for treating or preventing an inflammatory skin disorder |
WO2013019974A1 (en) * | 2011-08-02 | 2013-02-07 | Medicis Pharmaceutical Corporation | Compositions comprising a retinoid and a lincosamide antibiotic for use in treating rosacea |
US9775802B2 (en) | 2009-03-24 | 2017-10-03 | Bausch & Lomb Incorporated | Method for preparing suspensions of low-solubility materials |
US11213587B2 (en) | 2010-11-22 | 2022-01-04 | Bausch Health Ireland Limited | Pharmaceutical formulations containing corticosteroids for topical administration |
US11648256B2 (en) | 2015-06-18 | 2023-05-16 | Bausch Health Ireland Limited | Topical compositions and methods for treating psoriasis |
US11839656B2 (en) | 2010-11-22 | 2023-12-12 | Bausch Health Ireland Limited | Pharmaceutical formulations containing corticosteroids for topical administration |
Families Citing this family (137)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020048596A1 (en) * | 1994-12-30 | 2002-04-25 | Gregor Cevc | Preparation for the transport of an active substance across barriers |
AUPN814496A0 (en) * | 1996-02-19 | 1996-03-14 | Monash University | Dermal penetration enhancer |
DK1031347T3 (en) | 1999-01-27 | 2002-07-08 | Idea Ag | Transnasal transport / immunization with highly customizable carriers |
ATE216875T1 (en) | 1999-01-27 | 2002-05-15 | Idea Ag | NON-INVASIVE VACCINATION THROUGH THE SKIN |
MXPA02000053A (en) * | 1999-07-05 | 2003-07-21 | Idea Ag | A method for the improvement of transport across adaptable semi-permeable barriers. |
US6387383B1 (en) * | 2000-08-03 | 2002-05-14 | Dow Pharmaceutical Sciences | Topical low-viscosity gel composition |
US7060732B2 (en) * | 2000-12-12 | 2006-06-13 | Imaginative Research Associates, Inc. | Antibiotic/benzoyl peroxide dispenser |
US20060189552A1 (en) * | 2000-12-12 | 2006-08-24 | Mohan Vishnupad | Dispenser for dispensing three or more actives |
WO2002089743A2 (en) | 2001-05-09 | 2002-11-14 | The Regents Of The University Of Michigan | Use of compositions for treating rosacea |
US7368122B1 (en) * | 2002-03-08 | 2008-05-06 | Dow Pharmaceutical Sciences | Skin cream |
US20050186141A1 (en) * | 2002-06-25 | 2005-08-25 | Acrux Dds Pty Ltd. | Transdermal aerosol compositions |
NZ537360A (en) | 2002-06-25 | 2006-09-29 | Acrux Dds Pty Ltd | Transdermal delivery rate control using amorphous pharmaceutical compositions |
US20050181032A1 (en) * | 2002-06-25 | 2005-08-18 | Acrux Dds Pty Ltd. | Metastable pharmaceutical compositions |
US20040171561A1 (en) * | 2002-09-03 | 2004-09-02 | Popp Karl F. | Topical formulations for treatment of rosacea |
US20040167223A1 (en) * | 2002-09-03 | 2004-08-26 | Popp Karl F. | Topical antibacterial formulations |
US6906014B2 (en) * | 2002-09-10 | 2005-06-14 | Permatex, Inc. | Stabilized topical composition |
US7473432B2 (en) * | 2002-10-11 | 2009-01-06 | Idea Ag | NSAID formulations, based on highly adaptable aggregates, for improved transport through barriers and topical drug delivery |
US7208485B2 (en) * | 2003-01-13 | 2007-04-24 | Chemagis Ltd. | Crystalline forms of halobetasol propionate |
MXPA05007722A (en) | 2003-01-24 | 2006-01-31 | Connetics Australia Pty Ltd | Clindamycin phosphate foam. |
US20060135607A1 (en) * | 2003-02-07 | 2006-06-22 | Mochida Pharmaceutical Co., Ltd. | Drug for improving prognosis for subarachnoid hemorrhage |
US20040202726A1 (en) * | 2003-04-10 | 2004-10-14 | Deshay Samuel L. | Topical blood pressure composition |
US8410102B2 (en) | 2003-05-27 | 2013-04-02 | Galderma Laboratories Inc. | Methods and compositions for treating or preventing erythema |
US7439241B2 (en) | 2003-05-27 | 2008-10-21 | Galderma Laboratories, Inc. | Compounds, formulations, and methods for treating or preventing rosacea |
TW200510412A (en) | 2003-08-12 | 2005-03-16 | 3M Innovative Properties Co | Oxime substituted imidazo-containing compounds |
CA2536136C (en) | 2003-08-27 | 2012-10-30 | 3M Innovative Properties Company | Aryloxy and arylalkyleneoxy substituted imidazoquinolines |
JP2007504269A (en) | 2003-09-05 | 2007-03-01 | スリーエム イノベイティブ プロパティズ カンパニー | Method for treating CD5 + B cell lymphoma |
US20060140990A1 (en) * | 2003-09-19 | 2006-06-29 | Drugtech Corporation | Composition for topical treatment of mixed vaginal infections |
MY144021A (en) * | 2003-09-19 | 2011-07-29 | Drugtech Corp | Pharmaceutical delivery system |
DE60317579T2 (en) * | 2003-09-23 | 2008-09-18 | Akciju Sabiedriba "Olainfarm" | POLYMERS 3,5-DIMETHYL-1-ADAMANTYLAMMONIUM SALT AND THEIR USE IN THE FORM OF VIRUSTATIKA |
US7544697B2 (en) | 2003-10-03 | 2009-06-09 | Coley Pharmaceutical Group, Inc. | Pyrazolopyridines and analogs thereof |
JP5043435B2 (en) | 2003-10-03 | 2012-10-10 | スリーエム イノベイティブ プロパティズ カンパニー | Alkoxy substituted imidazoquinolines |
US20050095215A1 (en) * | 2003-11-03 | 2005-05-05 | Popp Karl F. | Antimicrobial shampoo compositions |
AU2004291122A1 (en) * | 2003-11-14 | 2005-06-02 | 3M Innovative Properties Company | Hydroxylamine substituted imidazo ring compounds |
CN1906193A (en) | 2003-11-14 | 2007-01-31 | 3M创新有限公司 | Oxime substituted imidazo ring compounds |
AR046781A1 (en) | 2003-11-25 | 2005-12-21 | 3M Innovative Properties Co | IMIDAZOQUINOLINE DERIVATIVES. PHARMACEUTICAL COMPOSITIONS. |
WO2005066170A1 (en) | 2003-12-29 | 2005-07-21 | 3M Innovative Properties Company | Arylalkenyl and arylalkynyl substituted imidazoquinolines |
WO2005066169A2 (en) | 2003-12-30 | 2005-07-21 | 3M Innovative Properties Company | Imidazoquinolinyl, imidazopyridinyl, and imidazonaphthyridinyl sulfonamides |
US20050139808A1 (en) * | 2003-12-30 | 2005-06-30 | Oculus Innovative Sciences, Inc. | Oxidative reductive potential water solution and process for producing same |
AU2004311432A1 (en) * | 2003-12-30 | 2005-07-21 | Oculus Innovative Sciences, Inc. | Oxidative reductive potential water solution, processes for producing same and methods of using the same |
US20050147570A1 (en) * | 2004-01-06 | 2005-07-07 | Nordsiek Michael T. | Methods of administering diclofenac compositions for treating photodamaged skin, rosacea and/or acne |
WO2005094531A2 (en) | 2004-03-24 | 2005-10-13 | 3M Innovative Properties Company | Amide substituted imidazopyridines, imidazoquinolines, and imidazonaphthyridines |
US20050255131A1 (en) * | 2004-05-11 | 2005-11-17 | Mohan Vishnupad | Clindamycin compositions and delivery system therefor |
US20060014834A1 (en) * | 2004-05-11 | 2006-01-19 | Mohan Vishnupad | Retinoid solutions and formulations made therefrom |
US7662855B2 (en) * | 2004-05-11 | 2010-02-16 | Imaginative Research Associates, Inc. | Retinoid solutions and formulations made therefrom |
BRPI0511519A (en) | 2004-05-25 | 2007-12-26 | Sansrosa Pharmaceutical Dev In | method for treating or preventing an inflammatory skin disorder and the symptoms associated with it, topical composition suitable for treating or preventing the symptoms of an inflammatory dermatological disorder, and packaging for a topical composition |
US20070196452A1 (en) * | 2004-06-07 | 2007-08-23 | Jie Zhang | Flux-enabling compositions and methods for dermal delivery of drugs |
US8741332B2 (en) * | 2004-06-07 | 2014-06-03 | Nuvo Research Inc. | Compositions and methods for dermally treating neuropathic pain |
US8741333B2 (en) * | 2004-06-07 | 2014-06-03 | Nuvo Research Inc. | Compositions and methods for treating dermatitis or psoriasis |
US8907153B2 (en) | 2004-06-07 | 2014-12-09 | Nuvo Research Inc. | Adhesive peel-forming formulations for dermal delivery of drugs and methods of using the same |
US8017779B2 (en) | 2004-06-15 | 2011-09-13 | 3M Innovative Properties Company | Nitrogen containing heterocyclyl substituted imidazoquinolines and imidazonaphthyridines |
FR2887149B1 (en) * | 2005-06-17 | 2007-08-03 | Galderma Sa | PROCESS FOR SOLUBILIZING THE METRONIDAZOLE |
US7897609B2 (en) | 2004-06-18 | 2011-03-01 | 3M Innovative Properties Company | Aryl substituted imidazonaphthyridines |
US7915281B2 (en) | 2004-06-18 | 2011-03-29 | 3M Innovative Properties Company | Isoxazole, dihydroisoxazole, and oxadiazole substituted imidazo ring compounds and method |
WO2006009826A1 (en) | 2004-06-18 | 2006-01-26 | 3M Innovative Properties Company | Aryloxy and arylalkyleneoxy substituted thiazoloquinolines and thiazolonaphthyridines |
WO2006009832A1 (en) * | 2004-06-18 | 2006-01-26 | 3M Innovative Properties Company | Substituted imidazo ring systems and methods |
US20060093675A1 (en) * | 2004-10-29 | 2006-05-04 | Mathew Ebmeier | Intravaginal treatment of vaginal infections with metronidazole compositions |
JP2008519764A (en) * | 2004-11-09 | 2008-06-12 | イマジナティブ リサーチ アソシエィツ インコーポレーテッド | Retinoid solutions and formulations made from them |
US20080095722A1 (en) * | 2004-11-12 | 2008-04-24 | Idea Ag | Extended Surface Aggregates in the Treatment of Skin Conditions |
WO2006074003A2 (en) | 2004-12-30 | 2006-07-13 | 3M Innovative Properties Company | CHIRAL FUSED [1,2]IMIDAZO[4,5-c] RING COMPOUNDS |
US8034938B2 (en) | 2004-12-30 | 2011-10-11 | 3M Innovative Properties Company | Substituted chiral fused [1,2]imidazo[4,5-c] ring compounds |
WO2006084251A2 (en) | 2005-02-04 | 2006-08-10 | Coley Pharmaceutical Group, Inc. | Aqueous gel formulations containing immune reponse modifiers |
JP2008530113A (en) | 2005-02-11 | 2008-08-07 | コーリー ファーマシューティカル グループ,インコーポレイテッド | Oxime and hydroxyramine substituted imidazo [4,5-c] ring compounds and methods |
US7943610B2 (en) | 2005-04-01 | 2011-05-17 | 3M Innovative Properties Company | Pyrazolopyridine-1,4-diamines and analogs thereof |
US7943636B2 (en) | 2005-04-01 | 2011-05-17 | 3M Innovative Properties Company | 1-substituted pyrazolo (3,4-C) ring compounds as modulators of cytokine biosynthesis for the treatment of viral infections and neoplastic diseases |
WO2006121429A1 (en) * | 2005-05-06 | 2006-11-16 | Imaginative Research Associates, Inc. | Clindamycin compositions and delivery system therefor |
CA2605341A1 (en) * | 2005-05-09 | 2006-11-16 | Drugtech Corporation | Modified-release pharmaceutical compositions |
ES2607454T3 (en) | 2005-06-03 | 2017-03-31 | Acrux Dds Pty Ltd | Method and composition for transdermal testosterone delivery |
AR054805A1 (en) * | 2005-06-29 | 2007-07-18 | Stiefel Laboratories | TOPICAL COMPOSITIONS FOR SKIN TREATMENT |
KR20080055797A (en) * | 2005-08-23 | 2008-06-19 | 닛산 가가쿠 고교 가부시키 가이샤 | Sustained-release preparation |
US8324192B2 (en) | 2005-11-12 | 2012-12-04 | The Regents Of The University Of California | Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract |
US8497258B2 (en) | 2005-11-12 | 2013-07-30 | The Regents Of The University Of California | Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract |
US8679545B2 (en) | 2005-11-12 | 2014-03-25 | The Regents Of The University Of California | Topical corticosteroids for the treatment of inflammatory diseases of the gastrointestinal tract |
JP2009522362A (en) * | 2006-01-05 | 2009-06-11 | ドラッグテック コーポレイション | Drug delivery system |
BRPI0620908A2 (en) * | 2006-01-05 | 2011-11-29 | Drugtech Corp | pharmaceutical composition, vaginal antibacterial and antifungal delivery system and use of pharmaceutical composition |
US9107844B2 (en) * | 2006-02-03 | 2015-08-18 | Stiefel Laboratories Inc. | Topical skin treating compositions |
CA2645073A1 (en) * | 2006-03-08 | 2007-09-13 | Nuviance, Inc. | Transdermal drug delivery compositions and topical compositions for application on the skin |
PL2206494T3 (en) | 2006-03-31 | 2016-06-30 | Stiefel Res Australia Pty Ltd | Foamable suspension gel |
US20070280972A1 (en) * | 2006-04-25 | 2007-12-06 | Zars, Inc. | Adhesive solid gel-forming formulations for dermal drug delivery |
US7906506B2 (en) | 2006-07-12 | 2011-03-15 | 3M Innovative Properties Company | Substituted chiral fused [1,2] imidazo [4,5-c] ring compounds and methods |
BRPI0717769A2 (en) | 2006-10-17 | 2013-11-05 | Nuvo Res | GEL FORMULATION, METHOD FOR TREATMENT OF OSTEOARTHRITIS IN AN INDIVIDUAL SUFFERING FROM ARTICULAR PAIN, AND USE OF SODIUM DICLOFENAC |
US8466128B2 (en) * | 2007-01-30 | 2013-06-18 | Cypress Pharmaceuticals, Inc. | Hyaluronate compositions |
US20080287373A1 (en) * | 2007-05-17 | 2008-11-20 | Popp Karl F | Topical skin treating kits |
US20080312245A1 (en) * | 2007-06-12 | 2008-12-18 | Longyan Xiao | Methods and compositions for treating acne and other infectious diseases |
WO2009036368A2 (en) | 2007-09-14 | 2009-03-19 | Nitto Denko Corporation | Drug carriers |
US20090098191A1 (en) * | 2007-10-16 | 2009-04-16 | Anderson Christopher G | Use of bases to stabilize transdermal formulations |
JP2011500687A (en) * | 2007-10-18 | 2011-01-06 | メディシス・ファーマシューティカル・コーポレーション | Aqueous retinoid and benzoyl peroxide gels |
US20100216754A1 (en) * | 2007-11-13 | 2010-08-26 | Meritage Pharma, Inc. | Compositions for the treatment of inflammation of the gastrointestinal tract |
US20090123551A1 (en) * | 2007-11-13 | 2009-05-14 | Meritage Pharma, Inc. | Gastrointestinal delivery systems |
US20090131386A1 (en) * | 2007-11-13 | 2009-05-21 | Meritage Pharma, Inc. | Compositions for the treatment of inflammation of the gastrointestinal tract |
PL3354276T3 (en) * | 2007-11-13 | 2020-09-21 | Meritage Pharma, Inc. | Compositions for the treatment of gastrointestinal inflammation |
BRPI0822095A2 (en) | 2007-12-21 | 2014-10-07 | Galderma Lab Inc | METHOD FOR REDUCING BLEEDING AND / OR HEMATOMA IN A PATIENT |
US20090176719A1 (en) * | 2008-01-07 | 2009-07-09 | Liolabs Llc | Compositions and methods for treating perioral dermatitis |
MX2010010111A (en) * | 2008-03-17 | 2010-12-15 | Glenmark Pharmaceuticals Ltd | Topical formulation comprising adapalene microspheres and clindamycin. |
US20090264392A1 (en) * | 2008-04-21 | 2009-10-22 | Meritage Pharma, Inc. | Treating eosinophilic esophagitis |
KR20110021888A (en) * | 2008-05-16 | 2011-03-04 | 갈데르마 리써어치 앤드 디벨로프먼트 | Therapy regimen for treating acne related diseases |
CN102056481A (en) | 2008-06-05 | 2011-05-11 | 陶氏制药科学公司 | Topical pharmaceutical formulations containing a low concentration of benzoyl peroxide in suspension in water and a water-miscible organic solvent |
EP2293777B1 (en) * | 2008-06-24 | 2015-02-25 | Intervet International B.V. | Pharmaceutical transdermal compositions and method for treating inflammation in cattle |
US20100105750A1 (en) * | 2008-10-23 | 2010-04-29 | Nycomed Us Inc. | Stable metronidazole gel formulations |
US8618164B2 (en) | 2009-03-31 | 2013-12-31 | Nuvo Research Inc. | Treatment of pain with topical diclofenac compounds |
US20110097401A1 (en) * | 2009-06-12 | 2011-04-28 | Meritage Pharma, Inc. | Methods for treating gastrointestinal disorders |
EP3141246A1 (en) | 2009-08-31 | 2017-03-15 | Dr. Reddy's Laboratories Ltd. | Topical formulations comprising a steroid |
US8394800B2 (en) | 2009-11-19 | 2013-03-12 | Galderma Laboratories, L.P. | Method for treating psoriasis |
AU2011231544B2 (en) | 2010-03-26 | 2015-01-15 | Galderma Research & Development | Improved methods and compositions for safe and effective treatment of telangiectasia |
MX2012010824A (en) | 2010-03-26 | 2012-10-10 | Galderma Res & Dev | Improved methods and compositions for safe and effective treatment of erythema. |
AU2011273509A1 (en) | 2010-06-30 | 2013-06-13 | Galderma Research & Development | Use of alpha-adrenergic receptor agonist for preventing or treating skin tumor |
WO2012001065A2 (en) | 2010-06-30 | 2012-01-05 | Galderma Research & Development | Method for preventing or treating skin tumor |
WO2012052479A2 (en) | 2010-10-21 | 2012-04-26 | Galderma S.A. | Brimonidine gel compositions and methods of use |
US8053427B1 (en) | 2010-10-21 | 2011-11-08 | Galderma R&D SNC | Brimonidine gel composition |
WO2013016072A1 (en) | 2011-07-22 | 2013-01-31 | Allergan, Inc. | Pharmaceutical compositions comprising 4-bromo-n-(imidazolidin-2-ylidene)-1h-benzimidazol-5-amine for treating skin diseases |
WO2013057580A1 (en) | 2011-10-19 | 2013-04-25 | Galderma Pharma S.A. | Method for treating capillary hemangiomas |
US9744168B2 (en) | 2011-10-19 | 2017-08-29 | Galderma Laboratories, Inc. | Method of reducing facial flushing associated with systemic use of phosphodiesterase type 5 inhibitors |
UA109359C2 (en) | 2011-11-10 | 2015-08-10 | TREATMENT OF SKIN DISEASES AND STATES | |
US9283217B2 (en) | 2011-11-10 | 2016-03-15 | Allergan, Inc. | Pharmaceutical compositions comprising 7-(1 H-imidazol-4-ylmethyl)-5,6,7,8-tetrahydro-quinoline for treating skin diseases and conditions |
RU2548714C2 (en) * | 2012-05-03 | 2015-04-20 | Открытое акционерное общество "Химико-фармацевтический комбинат "АКРИХИН" (ОАО "АКРИХИН") | Pharmaceutical composition for treating acne and method for preparing it |
US8962028B2 (en) | 2012-10-18 | 2015-02-24 | MiCal Pharmaceuticals LLC—H Series, a Series of MiCal Pharmaceuticals LLC, a Multi-Division Limited Liability Company | Topical steroid composition and method |
RU2530644C2 (en) * | 2012-11-01 | 2014-10-10 | Открытое акционерное общество "Химико-фармацевтический комбинат "АКРИХИН" (ОАО "АКРИХИН") | Comedolytic pharmaceutical composition and method for preparing it |
AU2014207618A1 (en) | 2013-01-16 | 2015-08-06 | Emory University | Cas9-nucleic acid complexes and uses related thereto |
AU2014326298B2 (en) | 2013-09-26 | 2019-07-04 | Galderma Holding SA | Prostaglandin F2alpha and analogues thereof for treating atrophic cutaneous scarring |
US20150250697A1 (en) * | 2014-03-07 | 2015-09-10 | The Procter & Gamble Company | Personal Care Compositions and Methods of Making Same |
US20160184431A1 (en) | 2014-03-11 | 2016-06-30 | Promius Pharma Llc | Topical compositions comprising a corticosteroid |
US9012402B1 (en) * | 2014-06-11 | 2015-04-21 | James Blanchard | Gel for topical delivery of NSAIDs to provide relief of musculoskeletal pain and methods for its preparation |
CN104473865A (en) * | 2014-11-17 | 2015-04-01 | 重庆华邦制药有限公司 | Desonide gel and preparation method thereof |
EP4349414A2 (en) | 2014-12-23 | 2024-04-10 | Dyve Biosciences, Inc. | Methods and formulations for transdermal administration |
US10117911B2 (en) | 2015-05-29 | 2018-11-06 | Agenovir Corporation | Compositions and methods to treat herpes simplex virus infections |
MX2018000421A (en) | 2015-07-13 | 2018-05-17 | Dr Reddy´S Laboratories Ltd | Topical retinoid compositions. |
CN106474047A (en) * | 2015-08-27 | 2017-03-08 | 重庆华邦制药有限公司 | A kind of desonide preparation stable to light |
CN106474048A (en) * | 2015-08-27 | 2017-03-08 | 重庆华邦制药有限公司 | A kind of more stable desonide gel preparation of quality |
CN106474059A (en) * | 2015-08-27 | 2017-03-08 | 重庆华邦制药有限公司 | A kind of more stable desonide lotion of quality |
WO2017172761A1 (en) | 2016-03-28 | 2017-10-05 | Allergan, Inc. | Phenyl urea derivatives as n-formyl peptide receptor modulators |
WO2018213310A1 (en) | 2017-05-15 | 2018-11-22 | Cornell University | Device and system for repairing intervertebral disc herniation and methods of use |
US10779525B2 (en) | 2018-01-16 | 2020-09-22 | Zin Research LLC | Treatment compound and method of application for hoof or foot disease in animals |
US10653656B2 (en) * | 2018-04-05 | 2020-05-19 | Bausch Health Ireland Limited | Topical pharmaceutical compositions for treating skin conditions |
US20200138822A1 (en) * | 2018-11-06 | 2020-05-07 | Tim COTE | Topical compositions comprising pentoxifylline and methods of treatment using the same |
FR3090385B1 (en) * | 2018-12-21 | 2021-01-08 | Pf Medicament | Emollient composition in the form of an emulsion |
CN111743853A (en) * | 2019-03-29 | 2020-10-09 | 天津金耀集团有限公司 | External pharmaceutical composition of near-neutral hydrocortisone butyrate |
EP4192431A1 (en) | 2020-08-04 | 2023-06-14 | Venthera, Inc. | Formulations of phosphoinositide 3-kinase inhibitors |
US20220202841A1 (en) * | 2020-12-24 | 2022-06-30 | Erine A. Kupetsky | Dermatological formulations for treatment of dermatitis |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6106848A (en) * | 1996-09-20 | 2000-08-22 | Centre International De Recherches Dermatologiques | Topically applicable O/W emulsions having high glycol content and at least one biologically active agent |
Family Cites Families (38)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3969516A (en) | 1974-12-19 | 1976-07-13 | Nelson Research & Development Company | Composition and method for treatment of acne |
US4497794A (en) | 1980-12-08 | 1985-02-05 | Dermik Laboratories, Inc. | Erythromycin/benzoyl peroxide composition for the treatment of acne |
US4361584A (en) | 1977-10-07 | 1982-11-30 | A.H.C. Pharmacal, Inc. | Composition and method for the treatment of acne |
US4247547A (en) | 1979-03-19 | 1981-01-27 | Johnson & Johnson | Tretinoin in a gel vehicle for acne treatment |
US4387107A (en) | 1979-07-25 | 1983-06-07 | Dermik Laboratories, Inc. | Stable benzoyl peroxide composition |
US4692329A (en) | 1980-12-08 | 1987-09-08 | William H. Rorer, Inc. | Erythromycin/benzoyl peroxide antiacne compositions |
LU83173A1 (en) | 1981-02-27 | 1981-06-05 | Oreal | NOVEL COSMETIC COMPOSITIONS FOR THE TREATMENT OF HAIR AND SKIN CONTAINING POWDER RESULTING FROM THE SPRAYING OF AT LEAST ONE PLANT AND A COHESION AGENT |
US4514385A (en) | 1981-10-05 | 1985-04-30 | Alcon Laboratories, Inc. | Anti-acne compositions |
CH643138A5 (en) * | 1983-08-29 | 1984-05-30 | Mepha Ag | INDOMETHACIN CONTAINING, gelatinous OINTMENT. |
LU85111A1 (en) | 1983-12-01 | 1985-09-12 | Oreal | ANTI-ACNETIC COMPOSITION BASED ON BENZOYL PEROXIDE AND AT LEAST ONE SOLAR FILTER |
US5446028A (en) | 1985-12-12 | 1995-08-29 | Dermik Laboratories, Inc. | Anti-acne method and composition |
FR2604357B1 (en) | 1986-09-30 | 1988-12-02 | Oreal | PHARMACEUTICAL AND ANTI-ACNE COSMETIC COMPOSITION |
AU618517B2 (en) | 1986-12-23 | 1992-01-02 | Eugene J. Van Scott | Additives enhancing topical actions of therapeutic agents |
WO1988006888A1 (en) * | 1987-03-20 | 1988-09-22 | Curatek Pharmaceuticals, Inc. | Novel topical metronidazole formulations and therapeutic uses thereof |
MY105521A (en) * | 1989-04-17 | 1994-10-31 | Healthpoint Ltd | Moisturizing vehicle for topical application of vitamin a acid. |
US5721275A (en) | 1989-06-07 | 1998-02-24 | Bazzano; Gail S. | Slow release vehicles for minimizing skin irritancy of topical compositions |
US5122519A (en) * | 1989-06-27 | 1992-06-16 | American Cyanamid Company | Stable, cosmetically acceptable topical gel formulation and method of treatment for acne |
GB9021320D0 (en) | 1990-10-01 | 1990-11-14 | Diomed Dev Ltd | Compositions for topical application |
US5380528A (en) | 1990-11-30 | 1995-01-10 | Richardson-Vicks Inc. | Silicone containing skin care compositions having improved oil control |
DE69208098T2 (en) * | 1991-10-16 | 1996-08-08 | Richardson Vicks Inc | AQUEOUS, COSMETIC GEL, WITH LOW PH, CONTAINING NON-IONOGENIC POLYACRYLAMIDE DERIVATIVES |
JP3190441B2 (en) * | 1992-07-20 | 2001-07-23 | エーザイ株式会社 | Stable formulation containing azelastine hydrochloride |
US5549914A (en) * | 1992-12-14 | 1996-08-27 | Sween Corporation | Heat stable wound care gel |
SK279919B6 (en) | 1993-07-01 | 1999-05-07 | Yamanouchi Europe B.V. | Pharmaceutical and cosmetic agent for topical skin application |
US5482710A (en) | 1993-07-30 | 1996-01-09 | Chesebrough-Pond'usa Co., Division Of Conopco, Inc. | Cosmetic composition for treatment of pimples and redness |
US5382432A (en) | 1993-11-15 | 1995-01-17 | Elizabeth Arden Company, Division Of Conopco, Inc. | Cosmetic method for treatment of skin |
US5466446A (en) | 1994-02-16 | 1995-11-14 | Stiefel Laboratories, Inc. | Topical compositions containing bensoyl peroxide and clindamycin and method of use thereof |
US5538732A (en) | 1994-04-12 | 1996-07-23 | Creative Products Resource, Inc. | Medicated applicator sheet for topical drug delivery |
US5451405A (en) | 1994-04-25 | 1995-09-19 | Chesebrough-Pond's Usa Co. | Skin treatment composition |
US5445823A (en) | 1994-10-20 | 1995-08-29 | The Procter & Gamble Company | Dermatological compositions and method of treatment of skin lesions therewith |
US5562917A (en) * | 1994-12-23 | 1996-10-08 | Pentech Pharmaceuticals, Inc. | Transdermal administration of apomorphine |
AT408067B (en) | 1995-03-17 | 2001-08-27 | Gebro Pharma Gmbh | PHARMACEUTICAL COMPOSITION FOR TOPICAL APPLICATION AND METHOD FOR THE PRODUCTION THEREOF |
EP0738510A3 (en) | 1995-04-20 | 2005-12-21 | L'oreal | Use of a HMG-CoA reductase inhibitor as an anti-ageing agent and as an anti-acne agent. Composition comprising at least one HMG-CoA reductase inhibitor and at least one active substance with scaling properties. |
US5750122A (en) | 1996-01-16 | 1998-05-12 | The Procter & Gamble Company | Compositions for treating hair or skin |
JP3193617B2 (en) * | 1996-01-29 | 2001-07-30 | カネボウ株式会社 | Refreshing agent and composition for human body |
US5891451A (en) | 1996-06-25 | 1999-04-06 | Elizabeth Arden Company, Division Of Conopco, Inc. | Skin treatment with salicylic acid esters |
JPH1179948A (en) * | 1997-09-12 | 1999-03-23 | Noevir Co Ltd | Hair tonic and hair cosmetic, and preparation for external use for skin for suppressing sebum secretion |
US6083996A (en) * | 1997-11-05 | 2000-07-04 | Nexmed Holdings, Inc. | Topical compositions for NSAI drug delivery |
US6387383B1 (en) * | 2000-08-03 | 2002-05-14 | Dow Pharmaceutical Sciences | Topical low-viscosity gel composition |
-
2000
- 2000-08-03 US US09/632,508 patent/US6387383B1/en not_active Expired - Lifetime
-
2001
- 2001-07-24 ZA ZA200301037A patent/ZA200301037B/en unknown
- 2001-07-24 ES ES08020820.0T patent/ES2437321T3/en not_active Expired - Lifetime
- 2001-07-24 RU RU2003105831/15A patent/RU2251410C2/en active IP Right Revival
- 2001-07-24 PT PT80208200T patent/PT2052714E/en unknown
- 2001-07-24 DE DE60138549T patent/DE60138549D1/en not_active Expired - Lifetime
- 2001-07-24 CN CN018150659A patent/CN1460013B/en not_active Expired - Lifetime
- 2001-07-24 SI SI200131027T patent/SI2052714T1/en unknown
- 2001-07-24 AU AU2001279002A patent/AU2001279002B2/en active Active
- 2001-07-24 ES ES01957238T patent/ES2326955T3/en not_active Expired - Lifetime
- 2001-07-24 SI SI200130926T patent/SI1304992T1/en unknown
- 2001-07-24 KR KR1020087008303A patent/KR20080036246A/en not_active Application Discontinuation
- 2001-07-24 KR KR1020037001564A patent/KR100840169B1/en active IP Right Grant
- 2001-07-24 PT PT01957238T patent/PT1304992E/en unknown
- 2001-07-24 MX MXPA03001006A patent/MXPA03001006A/en active IP Right Grant
- 2001-07-24 DK DK08020820.0T patent/DK2052714T3/en active
- 2001-07-24 CA CA2417646A patent/CA2417646C/en not_active Expired - Lifetime
- 2001-07-24 AU AU7900201A patent/AU7900201A/en active Pending
- 2001-07-24 DK DK01957238T patent/DK1304992T3/en active
- 2001-07-24 WO PCT/US2001/023341 patent/WO2002011683A1/en active Application Filing
- 2001-07-24 AT AT01957238T patent/ATE429922T1/en active
- 2001-07-24 PL PL360589A patent/PL213237B1/en unknown
- 2001-07-24 EP EP01957238A patent/EP1304992B1/en not_active Expired - Lifetime
- 2001-07-24 CN CN2008100852167A patent/CN101305982B/en not_active Expired - Lifetime
- 2001-07-24 BR BR0113247-4A patent/BR0113247A/en active IP Right Grant
- 2001-07-24 EP EP08020820.0A patent/EP2052714B1/en not_active Expired - Lifetime
- 2001-07-24 JP JP2002517021A patent/JP4988129B2/en not_active Expired - Lifetime
- 2001-07-31 AR ARP010103660A patent/AR030093A1/en not_active Application Discontinuation
-
2002
- 2002-03-08 US US10/096,516 patent/US6517847B2/en not_active Expired - Lifetime
-
2009
- 2009-05-18 HK HK09104488.2A patent/HK1125847A1/en not_active IP Right Cessation
- 2009-06-29 CY CY20091100677T patent/CY1109189T1/en unknown
-
2013
- 2013-10-30 BE BE2013C060C patent/BE2013C060I2/nl unknown
- 2013-11-21 CY CY20131101045T patent/CY1114646T1/en unknown
-
2014
- 2014-01-23 CY CY2014005C patent/CY2014005I2/en unknown
- 2014-03-18 LU LU92401C patent/LU92401I2/en unknown
- 2014-07-04 FR FR14C0053C patent/FR14C0053I1/en active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6106848A (en) * | 1996-09-20 | 2000-08-22 | Centre International De Recherches Dermatologiques | Topically applicable O/W emulsions having high glycol content and at least one biologically active agent |
Cited By (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7175850B2 (en) | 1998-12-23 | 2007-02-13 | Idea Ag | Formulation for topical non-invasive application in vivo |
WO2002074290A3 (en) * | 2001-03-15 | 2004-02-19 | Agis Ind 1983 Ltd | Dermatological preparations containing a nsaid |
JP2007522077A (en) * | 2003-08-21 | 2007-08-09 | アクセス ファーマシューティカルズ, インコーポレイテッド | Liquid formulations for prevention and treatment of mucosal diseases and disorders |
WO2006006054A1 (en) * | 2004-07-09 | 2006-01-19 | Universita' Degli Studi Di Roma 'tor Vergata' | Method for preparing a polymeric biocompatible system for the pharmacological release by topic use and use of said system |
WO2010111115A1 (en) * | 2009-03-24 | 2010-09-30 | Bausch & Lomb Incorporated | Method for preparing suspensions of low-solubility materials |
US9775802B2 (en) | 2009-03-24 | 2017-10-03 | Bausch & Lomb Incorporated | Method for preparing suspensions of low-solubility materials |
AU2010320911B2 (en) * | 2009-11-18 | 2013-09-12 | Galderma Research & Development | Combination of alpha- 2 adrenergic receptor agonist and non-steroidal anti - inflammatory agent for treating or preventing an inflammatory skin disorder |
WO2011061252A3 (en) * | 2009-11-18 | 2011-11-17 | Galderma Research & Development | Combination of alpha- 2 adrenergic receptor agonist and non-steroidal anti - inflammatory agent for treating or preventing an inflammatory skin disorder |
US9186358B2 (en) | 2009-11-18 | 2015-11-17 | Galderma Laboratories, L.P. | Combination therapy for treating or preventing an inflammatory skin disorder |
EP2329849A1 (en) * | 2009-11-18 | 2011-06-08 | Galderma Research & Development | Combination of alpha-2 adrenergic receptor agonist and non-steroidal anti-inflammatory agent for treating or preventing an inflammatory skin disorder |
US11213587B2 (en) | 2010-11-22 | 2022-01-04 | Bausch Health Ireland Limited | Pharmaceutical formulations containing corticosteroids for topical administration |
US11839656B2 (en) | 2010-11-22 | 2023-12-12 | Bausch Health Ireland Limited | Pharmaceutical formulations containing corticosteroids for topical administration |
US11957753B2 (en) | 2010-11-22 | 2024-04-16 | Bausch Health Ireland Limited | Pharmaceutical formulations containing corticosteroids for topical administration |
WO2013019974A1 (en) * | 2011-08-02 | 2013-02-07 | Medicis Pharmaceutical Corporation | Compositions comprising a retinoid and a lincosamide antibiotic for use in treating rosacea |
US11648256B2 (en) | 2015-06-18 | 2023-05-16 | Bausch Health Ireland Limited | Topical compositions and methods for treating psoriasis |
US11679116B2 (en) | 2015-06-18 | 2023-06-20 | Bausch Health Ireland Limited | Topical compositions and methods for treating psoriasis |
US11679115B2 (en) | 2015-06-18 | 2023-06-20 | Bausch Health Ireland Limited | Topical compositions and methods for treating psoriasis |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6387383B1 (en) | Topical low-viscosity gel composition | |
AU2001279002A1 (en) | Topical gel delivery system | |
US6117843A (en) | Compositions for the treatment of acne containing clindamycin and benzoyl peroxide | |
AU666169B2 (en) | Compositions of clindamycin and benzoyl peroxide for acne treatment | |
US4247547A (en) | Tretinoin in a gel vehicle for acne treatment | |
CA2142530C (en) | Topical compositions containing benzoyl peroxide and clindamycin and method of use thereof | |
JP2009500336A (en) | Topical skin treatment composition | |
US7368122B1 (en) | Skin cream | |
US20040167223A1 (en) | Topical antibacterial formulations | |
US20100210571A1 (en) | Topical formulations for treatment of skin disorders | |
US20040171561A1 (en) | Topical formulations for treatment of rosacea | |
JP2011510907A (en) | Use of adapalene and benzoyl peroxide for long-term treatment of acne vulgaris | |
RU2548714C2 (en) | Pharmaceutical composition for treating acne and method for preparing it | |
Srivastava | Excipients for semisolid formulations | |
JP2023026516A (en) | Oily external liquid |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2417646 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2001279002 Country of ref document: AU Ref document number: PA/a/2003/001006 Country of ref document: MX |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1020037001564 Country of ref document: KR Ref document number: 2002517021 Country of ref document: JP Ref document number: 126/DELNP/2003 Country of ref document: IN |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2003/01037 Country of ref document: ZA Ref document number: 200301037 Country of ref document: ZA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2001957238 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref document number: 2003105831 Country of ref document: RU Kind code of ref document: A Ref country code: RU Ref document number: RU A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 018150659 Country of ref document: CN |
|
WWP | Wipo information: published in national office |
Ref document number: 2001957238 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWP | Wipo information: published in national office |
Ref document number: 1020037001564 Country of ref document: KR |